-
Something wrong with this record ?
Variable X-chromosome inactivation and enlargement of pericentral glutamine synthetase zones in the liver of heterozygous females with OTC deficiency
D. Musalkova, E. Sticova, M. Reboun, J. Sokolova, J. Krijt, J. Honzikova, J. Gurka, M. Neroldova, T. Honzik, J. Zeman, M. Jirsa, L. Dvorakova, M. Hrebicek,
Language English Country Germany
Document type Journal Article
NLK
ProQuest Central
from 2003-01-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2011-01-01 to 1 year ago
Nursing & Allied Health Database (ProQuest)
from 2003-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 2003-01-01 to 1 year ago
- MeSH
- Biopsy MeSH
- Genotype MeSH
- Glutamate-Ammonia Ligase genetics metabolism MeSH
- Heterozygote MeSH
- X Chromosome Inactivation * MeSH
- Liver enzymology MeSH
- Humans MeSH
- Chromosomes, Human, X genetics MeSH
- Ornithine Carbamoyltransferase Deficiency Disease genetics MeSH
- Ornithine Carbamoyltransferase genetics metabolism MeSH
- Sex Characteristics MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
Ornithine transcarbamylase (OTC) deficiency is an X-linked disorder that causes recurrent and life-threatening episodes of hyperammonemia. The clinical picture in heterozygous females is highly diverse and derives from the genotype and the degree of inactivation of the mutated X chromosome in hepatocytes. Here, we describe molecular genetic, biochemical, and histopathological findings in the livers explanted from two female patients with late-onset OTC deficiency. Analysis of X-inactivation ratios by DNA methylation-based assays showed remarkable intra-organ variation ranging from 46:54 to 82:18 (average 70:30, n = 37), in favor of the active X chromosome carrying the mutation c.583G>C (p.G195R), in the first patient and from 75:25 to 90:10 (average 82:18, n = 20) in favor of the active X chromosome carrying the splicing mutation c.663+1G>A in the second patient. The X-inactivation ratios in liver samples correlated highly with the proportions of OTC-positive hepatocytes calculated from high-resolution image analyses of the immunohistochemically detected OTC in frozen sections that was performed on total area > 5 cm2. X-inactivation ratios in blood in both female patients corresponded to the lower limit of the liver values. Our data indicate that the proportion of about 20-30% of hepatocytes expressing the functional OTC protein is not sufficient to maintain metabolic stability. X-inactivation ratios assessed in liver biopsies taken from heterozygous females with X-linked disorders should not be considered representative of the whole liver.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18024272
- 003
- CZ-PrNML
- 005
- 20181017072103.0
- 007
- ta
- 008
- 180709s2018 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00428-018-2345-x $2 doi
- 035 __
- $a (PubMed)29623395
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Musalkova, Dita $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 128 08, Prague 2, Czech Republic. dita.musalkova@lf1.cuni.cz.
- 245 10
- $a Variable X-chromosome inactivation and enlargement of pericentral glutamine synthetase zones in the liver of heterozygous females with OTC deficiency / $c D. Musalkova, E. Sticova, M. Reboun, J. Sokolova, J. Krijt, J. Honzikova, J. Gurka, M. Neroldova, T. Honzik, J. Zeman, M. Jirsa, L. Dvorakova, M. Hrebicek,
- 520 9_
- $a Ornithine transcarbamylase (OTC) deficiency is an X-linked disorder that causes recurrent and life-threatening episodes of hyperammonemia. The clinical picture in heterozygous females is highly diverse and derives from the genotype and the degree of inactivation of the mutated X chromosome in hepatocytes. Here, we describe molecular genetic, biochemical, and histopathological findings in the livers explanted from two female patients with late-onset OTC deficiency. Analysis of X-inactivation ratios by DNA methylation-based assays showed remarkable intra-organ variation ranging from 46:54 to 82:18 (average 70:30, n = 37), in favor of the active X chromosome carrying the mutation c.583G>C (p.G195R), in the first patient and from 75:25 to 90:10 (average 82:18, n = 20) in favor of the active X chromosome carrying the splicing mutation c.663+1G>A in the second patient. The X-inactivation ratios in liver samples correlated highly with the proportions of OTC-positive hepatocytes calculated from high-resolution image analyses of the immunohistochemically detected OTC in frozen sections that was performed on total area > 5 cm2. X-inactivation ratios in blood in both female patients corresponded to the lower limit of the liver values. Our data indicate that the proportion of about 20-30% of hepatocytes expressing the functional OTC protein is not sufficient to maintain metabolic stability. X-inactivation ratios assessed in liver biopsies taken from heterozygous females with X-linked disorders should not be considered representative of the whole liver.
- 650 _2
- $a biopsie $7 D001706
- 650 _2
- $a lidské chromozomy X $x genetika $7 D041321
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a genotyp $7 D005838
- 650 _2
- $a glutaminsynthetasa $x genetika $x metabolismus $7 D005974
- 650 _2
- $a heterozygot $7 D006579
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a játra $x enzymologie $7 D008099
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ornithinkarbamoyltransferasa $x genetika $x metabolismus $7 D009954
- 650 _2
- $a nemoc z nedostatku ornithinkarbamoyltransferázy $x genetika $7 D020163
- 650 _2
- $a pohlavní dimorfismus $7 D012727
- 650 12
- $a inaktivace chromozomu X $7 D049951
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Sticova, Eva $u Department of Clinical and Transplant Pathology, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic.
- 700 1_
- $a Reboun, Martin $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 128 08, Prague 2, Czech Republic.
- 700 1_
- $a Sokolova, Jitka $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 128 08, Prague 2, Czech Republic.
- 700 1_
- $a Krijt, Jakub $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 128 08, Prague 2, Czech Republic.
- 700 1_
- $a Honzíková, Jitka $7 xx0228095 $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 128 08, Prague 2, Czech Republic.
- 700 1_
- $a Gurka, Jiri $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 128 08, Prague 2, Czech Republic. Institute of Histology and Embryology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Neroldova, Magdalena $u Laboratory of Experimental Hepatology, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic.
- 700 1_
- $a Honzik, Tomas $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
- 700 1_
- $a Zeman, Jiri $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
- 700 1_
- $a Jirsa, Milan $u Laboratory of Experimental Hepatology, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic.
- 700 1_
- $a Dvorakova, Lenka $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 128 08, Prague 2, Czech Republic.
- 700 1_
- $a Hrebicek, Martin $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 128 08, Prague 2, Czech Republic. martin.hrebicek@lf1.cuni.cz.
- 773 0_
- $w MED00004660 $t Virchows Archiv an international journal of pathology $x 1432-2307 $g Roč. 472, č. 6 (2018), s. 1029-1039
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29623395 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180709 $b ABA008
- 991 __
- $a 20181017072601 $b ABA008
- 999 __
- $a ok $b bmc $g 1316403 $s 1021193
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 472 $c 6 $d 1029-1039 $e 20180406 $i 1432-2307 $m Virchows Archiv $n Virchows Arch $x MED00004660
- LZP __
- $a Pubmed-20180709